Aortic valve cyclic stretch causes increased remodeling activity and enhanced serotonin receptor responsiveness

Annals of Thoracic Surgery

Volumn 92, Issue 1, 2011, Pages 147-153

  Balachandran, Kartik ^a   Bakay, Marina A ^b   Connolly, Jeanne M ^b   Zhang, Xuemei ^b   Yoganathan, Ajit P ^a   Levy, Robert J ^b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; GLYCOSAMINOGLYCAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEOGLYCAN; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN TRANSPORTER;

ANIMAL CELL; ANIMAL TISSUE; AORTA VALVE; AORTIC VALVE CYCLIC STRETCH; ARTICLE; BIOMECHANICS; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; EXTRACELLULAR MATRIX; INTRACELLULAR SIGNALING; LEYDIG CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TENSILE STRENGTH; TISSUE REGENERATION;

ANIMALS; AORTIC VALVE; BIOMECHANICS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; EXTRACELLULAR MATRIX; FLUOXETINE; GLYCOSAMINOGLYCANS; HEART VALVE DISEASES; RANDOM ALLOCATION; RECEPTORS, SEROTONIN; REFERENCE VALUES; REGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAMPLING STUDIES; SIGNAL TRANSDUCTION; STRESS, MECHANICAL; SWINE; TISSUE CULTURE TECHNIQUES; UP-REGULATION;

EID: 79959797202     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.03.084     Document Type: Article

References (33)

1. P.A. Robiolio, V.H. Rigolin, and J.S. Wilson Carcinoid heart disease Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography Circulation 92 1995 790 795
2. J.E. Moller, H.M. Connolly, J. Rubin, J.B. Seward, K. Modesto, and P.A. Pellikka Factors associated with progression of carcinoid heart disease N Engl J Med 348 2003 1005 1015
3. H.M. Connolly, J.L. Crary, and M.D. McGoon Valvular heart disease associated with fenfluramine-phentermine N Engl J Med 337 1997 581 588
4. H. Jick, C. Vasilakis, L.A. Weinrauch, C.R. Meier, S.S. Jick, and L.E. Derby A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation N Engl J Med 339 1998 719 724
5. R.B. Rothman, M.H. Baumann, and J.E. Savage Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications Circulation 102 2000 2836 2841
6. L.W. Fitzgerald, T.C. Burn, and B.S. Brown Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine Mol Pharmacol 57 2000 75 81
7. V. Setola, M. Dukat, R.A. Glennon, and B.L. Roth Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor Mol Pharmacol 68 2005 20 33
8. X.P. Huang, V. Setola, and P.N. Yadav Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine(2B) receptor agonists: implications for drug safety assessment Mol Pharmacol 76 2009 710 722
9. A. Antonini, and W. Poewe Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease Lancet Neurol 6 2007 826 829
10. A.H. Chester, M. Misfeld, H.H. Sievers, and M.H. Yacoub Influence of 5-hydroxytryptamine on aortic valve competence in vitro J Heart Valve Dis 10 2001 822 826
11. N.M. Rajamannan, N. Caplice, and F. Anthikad Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects J Heart Valve Dis 10 2001 827 831
12. I. El-Hamamsy, K. Balachandran, and M.H. Yacoub Endothelium-dependent regulation of the mechanical properties of aortic valve cusps J Am Coll Cardiol 53 2009 1448 1455
13. R.A. Pea-Silva, J.D. Miller, Y. Chu, and D.D. Heistad Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves Am J Physiol Heart Circ Physiol 297 2009 H1354 H1360
14. S. Hafizi, P.M. Taylor, A.H. Chester, S.P. Allen, and M.H. Yacoub Mitogenic and secretory responses of human valve interstitial cells to vasoactive agents J Heart Valve Dis 9 2000 454 458
15. B. Jian, J. Xu, and J. Connolly Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells Am J Pathol 161 2002 2111 2121
16. J.M. Connolly, M.A. Bakay, and J.T. Fulmer Fenfluramine disrupts the mitral valve interstitial cell response to serotonin Am J Pathol 175 2009 988 997
17. B.I. Gustafsson, K. Tømmers, and I. Nordrum Long-term serotonin administration induces heart valve disease in rats Circulation 111 2005 1517 1522
18. S. Droogmans, P.R. Franken, and C. Garbar In vivo model of drug-induced valvular heart disease in rats: pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology Eur Heart J 28 2007 2156 2162
19. S. Disatian, C. Lacerda, and E.C. Orton Tryptophan hydroxylase 1 expression is increased in phenotype-altered canine and human degenerative myxomatous mitral valves J Heart Valve Dis 19 2010 71 78
20. S. Disatian, and E.C. Orton Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease J Heart Valve Dis 18 2009 44 51
21. S. Droogmans, B. Roosens, and B. Cosyns Dose dependency and reversibility of serotonin-induced valvular heart disease in rats Cardiovasc Toxicol 9 2009 134 141
22. M.R. Fielden, M. Hassani, and H. Uppal Mechanism of subendocardial cell proliferation in the rat and relevance for understanding drug-induced valvular heart disease in humans Exp Toxicol Pathol 62 2010 607 613
23. A. Mekontso-Dessap, F. Brouri, and O. Pascal Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice Circulation 113 2006 81 89
24. K. Balachandran, S. Konduri, P. Sucosky, H. Jo, and A.P. Yoganathan An ex vivo study of the biological properties of porcine aortic valves in response to circumferential cyclic stretch Ann Biomed Eng 34 2006 1655 1665
25. K. Balachandran, P. Sucosky, H. Jo, and A.P. Yoganathan Elevated cyclic stretch alters matrix remodeling in aortic valve cusps: implications for degenerative aortic valve disease Am J Physiol Heart Circ Physiol 296 2009 H756 H764
26. K. Balachandran, P. Sucosky, H. Jo, and A.P. Yoganathan Elevated cyclic stretch induces aortic valve calcification in a bone morphogenic protein-dependent manner Am J Pathol 177 2010 49 57
27. C.H. Yap, H.S. Kim, K. Balachandran, M. Weiler, R. Haj-Ali, and A.P. Yoganathan Dynamic deformation characteristics of porcine aortic valve leaflet under normal and hypertensive conditions Am J Physiol Heart Circ Physiol 298 2010 H395 H405
28. Y. Xing, J.N. Warnock, Z. He, S.L. Hilbert, and A.P. Yoganathan Cyclic pressure affects the biological properties of porcine aortic valve leaflets in a magnitude and frequency dependent manner Ann Biomed Eng 32 2004 1461 1470
29. L. Rich, and P. Whittaker Collagen and picosirius red staining: a poalrized light assessment of fibrillar hue and spatioal distribution Braz J Moorphol Sci 51 2005 1973 1981
30. N. Kurn, P. Chen, J.D. Heath, A. Kopf-Sill, K.M. Stephens, and S. Wang Novel isothermal, linear nucleic acid amplification systems for highly multiplexed applications Clin Chem 51 2005 1973 1981
31. J. Xu, B. Jian, and R. Chu Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells Am J Pathol 161 2002 2209 2218
32. S. Tsai, J.P. Cassady, B.A. Freking, D.J. Nonneman, G.A. Rohrer, and J.A. Piedrahita Annotation of the Affymetrix porcine genome microarray Anim Genet 37 2006 423 424
33. J.P. Steibel, M. Wysocki, and J.K. Lunney Assessment of the swine protein-annotated oligonucleotide microarray Anim Genet 40 2009 883 893